Wednesday, April 08, 2020 2:16:51 PM
$INO is a company heavily involved in experimenting on artificial pandemics and man made viruses for many years. The CEO and his buddy Dr. Weiner (INO founders) has the credentials and connections, now been given the go ahead to produce the corona virus vaccine!
Dr Joseph Kim: (CEO)
Created the PCV1 PCV2 Porcine Circovirus (PIG DNA) A couple of years after they were given the patent for this pig DNA vaccine using PCV2 that same ingredient was found to be in Merck’s $MRK Rotarix vaccine for diarrhoea and GSK vaccine Rotateq for diarrhoea Merck $MRK helped fund Dr. Kim for the creation of PCV1, PCV2
Dr. Kim has many Merck $MRK Insiders on his board
founder of VGXI, Inc.
Dr. Weiner:
A pioneer of DNA vaccinations, A leading DNA technology inventor the worlds DNA technology expert but he is also a special employee and adviser to the FDA and the NIH grant review process.
HIV pioneer.
He has perfected a new method of giving these DNA vaccines via Electroporation.
Dr. Weiner was highly involved in the Zika vaccine.
An advisor to GSK, Pfizer and other Pharma giants.
founder of VGXI, Inc.
Dr Joseph Kim: (CEO)
Created the PCV1 PCV2 Porcine Circovirus (PIG DNA) A couple of years after they were given the patent for this pig DNA vaccine using PCV2 that same ingredient was found to be in Merck’s $MRK Rotarix vaccine for diarrhoea and GSK vaccine Rotateq for diarrhoea Merck $MRK helped fund Dr. Kim for the creation of PCV1, PCV2
Dr. Kim has many Merck $MRK Insiders on his board
founder of VGXI, Inc.
Dr. Weiner:
A pioneer of DNA vaccinations, A leading DNA technology inventor the worlds DNA technology expert but he is also a special employee and adviser to the FDA and the NIH grant review process.
HIV pioneer.
He has perfected a new method of giving these DNA vaccines via Electroporation.
Dr. Weiner was highly involved in the Zika vaccine.
An advisor to GSK, Pfizer and other Pharma giants.
founder of VGXI, Inc.
Recent INO News
- INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 04/06/2026 07:46:00 AM
- INOVIO Announces Pricing of $17.5 Million Public Offering • PR Newswire (US) • 04/02/2026 12:55:00 PM
- INOVIO Announces Proposed Public Offering • PR Newswire (US) • 04/02/2026 12:05:00 AM
- INOVIO to Participate in Upcoming Scientific Conference • PR Newswire (US) • 04/01/2026 02:29:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/31/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 03/30/2026 07:47:00 AM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/24/2026 01:00:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/17/2026 01:00:00 PM
- INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/12/2026 08:05:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/10/2026 01:00:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 03/09/2026 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:55:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:54:42 PM
- INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • PR Newswire (US) • 03/05/2026 09:05:00 PM
- INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) • PR Newswire (US) • 03/04/2026 01:05:00 PM
- Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:49:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:48:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:44:20 PM
- Investors in Inovio Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 02/24/2026 02:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 02/23/2026 09:04:00 AM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 02/20/2026 09:27:00 AM
